News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlycoMark Receives More than $240,000 to Advance Blood Test for Diabetes and Pre-Diabetes



11/5/2010 11:14:56 AM

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--GlycoMark, a research and development company for diabetes testing, has been awarded $244,479 to advance the company’s innovative early detection algorithm for diabetes and pre-diabetes, which combines the hemoglobin A1c (HbA1c) and 1,5-anhydroglucitol (GlycoMark) blood tests. The company received the maximum allowable amount under the Qualifying Therapeutic Discovery Project (QTDP), part of the Patient Protection and Affordable Care Act of 2010.

Read at BioSpace.com


comments powered by Disqus
GlycoMark
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES